zetomipzomib
kezar
['lupus', 'mission trial', 'zetomipzomib', 'kezar']
this weekend, complete results from our phase 2 mission trial of zetomipzomib in patients with #lupusnephritis will be presented at the american college of rheumatology ( ) convergence. #acr22 more information here: 
Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease.